The effect of neoadjuvant chemotherapy on ductal carcinoma in situ in triple-negative breast cancer patients: A nationwide analysis

The effect of neoadjuvant chemotherapy on ductal carcinoma in situ in triple-negative breast cancer patients: A nationwide analysis

Purpose: Recent studies show that ductal carcinoma in situ (DCIS) accompanying HER2+ breast cancer can be completely eradicated following neoadjuvant systemic therapy in up to 52 %. We aimed to determine the complete response rate of DCIS in triple-negative breast cancer (TNBC) patients in a nationw...

Full description

Saved in:
Bibliographic Details
Main Authors: Eva L. Claassens, Roxanne A.W. Ploumen, Loes F.S. Kooreman, Maartje A.C.E. van Kats, Sabine Siesling, Thiemo J.A. van Nijnatten, Marjolein L. Smidt
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Breast
Subjects:
Ductal carcinoma in situ
Neoadjuvant chemotherapy
Pathologic complete response
Triple-negative breast cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S096097762500044X
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items